I completed my BSc (Hons) in Biochemistry at Kingston University London before getting an MRes in Biomedical Research at Imperial College London. During my MRes I began work in the field of metabonomics by developing a novel mass spectrometry (MS)-based platform to quantify nitric oxide-related amines from human plasma samples. I continued work in MS-based method development as a research assistant, on a project working to profile early pregnancy loss, prior to joining the National Centre for Mesothelioma Research (NCMR) as a PhD student.Metabonomics has proven to be a powerful tool for discovering biomarkers and elucidating mechanisms of disease in many cancers, particularly when combined with other genomic and transcriptomic data. Within the NCMR, my PhD project aims to apply a metabonomics approach to mesothelioma. I intend to do this by metabolically profiling patient-derived primary cells in the hope of revealing metabolic vulnerabilities which could be exploited to improve mesothelioma treatment and diagnostic approaches.